To effectively address critical questions related to the adoption and deployment of in silico methods for specific topics, the Avicenna Alliance has established dedicated Task Forces, composed of experts from various fields, ensuring a multidisciplinary approach to solving complex issues.
These groups collaborate to achieve concrete progress for matters as diverse as In silico AI, Patient involvement, Horizon Europe Projects, Pharmaceutical strategy, In silico oncology, Notified Bodies and Standard Organizations, etc.
By leveraging diverse expertise and fostering strong industry-academia relationships – each Task Force is led by 2 co-chairs one from academia and one from industry - the Task Forces aim to pave the way for widespread implementation and acceptance of in silico practices, ultimately benefiting patients and advancing scientific progress.
NEWS
News
Avicenna Days 2026 has been a great success - Thank you all !!!
We would like to extend a heartfelt thank you to all the speakers and panelists who contributed to Avicenna Days 2026. Your presentations, insights, and discussions made a real difference, bringing depth, energy, and forward-thinking perspectives to the event.
News
Be part of Avicenna Days 2026 — register to explore the future of in silico medicine with global experts
Join the voices shaping the future of in silico medicine - In 2026, the Avicenna Alliance celebrates a major milestone: 10 years of advancing in silico medicine — and you are invited to be part of what comes next.
News
Infrastructure or Collaboration? Advancing In Silico Medicine Together
Avicenna Days (AAD) 2026 - The Research & Technology Working Group